Estimates Revisions Bio-Techne Corporation
Equities
TECH
US09073M1045
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
75.01 USD | -0.32% |
|
+3.09% | +4.14% |
Feb. 06 | Scotiabank Adjusts Bio-Techne's Price Target to $90 From $88 | MT |
Feb. 06 | KeyBanc Adjusts Bio-Techne's Price Target to $90 From $80 | MT |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
EBIT - Evolution of Analysts' Estimates
Dividend / Share (DPS) - Evolution of Analysts' Estimates
Cash or Net Debt - Evolution of Analysts' Estimates
1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
---|---|---|---|---|
Average | ||||
Weighted average by Cap. |
Turnover
Earnings Per Share (EPS)
EBIT
Dividend / Share (DPS)
Cash or Net Debt
- Stock Market
- Equities
- TECH Stock
- Consensus Bio-Techne Corporation
- Estimates Revisions